secwatch / observer
8-K filed May 15, 2023, 7:59 PM ET ticker NRC CIK 0000070487
other material confidence high sentiment positive materiality 0.15

NRC annual meeting: all proposals pass with >96% support; directors elected for 3-year terms

NRC HEALTH

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NRC HEALTH shareholders approved Non-binding, advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement at the 2023-05-11 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-05-11
Exact text from the filing
The shareholders approved on an advisory basis the compensation of the Company's named executive officers as disclosed in the Company's proxy statement relating to the Annual Meeting.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NRC HEALTH shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2023 at the 2023-05-11 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-11
Exact text from the filing
The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2023.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NRC HEALTH shareholders approved Non-binding advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers at the 2023-05-11 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-05-11
Exact text from the filing
The shareholders approved on an non-binding, advisory basis the frequency of future non-binding, advisory votes to approve the compensation of the Company's named executive officers.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NRC HEALTH shareholders approved Election of two directors, Parul Bhandari and Penny A. Wheeler, for a three-year term to expire at the Company's 2026 annual meeting of shareholders at the 2023-05-11 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-11
Exact text from the filing
The shareholders elected Parul Bhandari and Penny A. Wheeler as directors for three-year terms to expire at the Company's 2026 annual meeting of shareholders.
View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

NRC HEALTH filing history →

Source: SEC EDGAR
accession 0001437749-23-014369
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.